Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.32 USD | +11.86% |
|
+8.20% | -55.25% |
Evolution of the average Target Price on BioXcel Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering BioXcel Therapeutics, Inc.
Canaccord Genuity | |
UBS | |
Truist Securities | |
HC Wainwright | |
Goldman Sachs | |
Mizuho Securities | |
Guggenheim | |
Jefferies & Co. | |
Berenberg Bank | |
BofA Securities |
EPS Revisions
- Stock Market
- Equities
- BTAI Stock
- Consensus BioXcel Therapeutics, Inc.